Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Evaluating the Usefulness of Compulsory Licensing in Developing Countries: A Comparative Study of Thai and Brazilian Experiences Regarding Access to Aids Treatments.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Guennif S
  • المصدر:
    Developing world bioethics [Dev World Bioeth] 2017 Aug; Vol. 17 (2), pp. 90-99. Date of Electronic Publication: 2016 Oct 04.
  • نوع النشر :
    Comparative Study; Journal Article
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101120122 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-8847 (Electronic) Linking ISSN: 14718731 NLM ISO Abbreviation: Dev World Bioeth Subsets: MEDLINE
    • بيانات النشر:
      Publication: 2014- : Abingdon : John Wiley & Sons Ltd.
      Original Publication: Oxford ; Malden, MA : Blackwell, c2001-
    • الموضوع:
    • نبذة مختصرة :
      While compulsory licensing (CL) is described in the TRIPS agreement as flexibility to protect public health by improving access to medicines in developing countries, a recent literature contends adversely that CL may harm public health. Therefore, this article intends to evaluate the usefulness of CL in the South through the prism of obligations and goals entrusted to patent holders (the effective and non-abusive exploitation of patents in order to achieve industrial and health developments) and in light of experiences in Thailand and Brazil regarding access to antiretroviral drugs. In this way, it shows that the obligations assigned to patent holders were better served by the recipients of CL and brought significant health and industrial benefits in the two high middle-income countries. In particular, CL allowed the scaling-up of free and universal access to antiretroviral drugs by assuring the financial sustainability of these public health programs endangered by monopolistic practices from patent holders.
      (© 2016 John Wiley & Sons Ltd.)
    • Contributed Indexing:
      Keywords: Drug accessibility; HIV/AIDS; compulsory licensing; developing countries; intellectual property rights; public health
    • الرقم المعرف:
      0 (Anti-Retroviral Agents)
    • الموضوع:
      Date Created: 20161005 Date Completed: 20180108 Latest Revision: 20181202
    • الموضوع:
      20231215
    • الرقم المعرف:
      10.1111/dewb.12124
    • الرقم المعرف:
      27699996